Brind.

The UN determined that Canada is not contributing fairly to innovation, while Health Canada handles drug approvals and US policy stalls launches.

Steady: 0 in the last 7 days Updated nov 3

The latest in this situation

  1. Lilly Canada sponsored an innovation challenge while HealthCareCAN highlighted access barriers in Canada.

How it started

1 report, 1 independent, last reported Aug 17. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The UN determined that Canada is not contributing fairly to innovation, while Health Canada handles drug approvals and US policy stalls launches.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Lilly Canada sponsored an innovation challenge while HealthCareCAN highlighted access barriers in Canada.Sub-event
  2. UN criticizes Canada's innovation funding; Health Canada approves drugs before market submission.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped